mhurhangee/ep-ind-claims huggingface dataset:
An image decoding method performed by an image decoding apparatus, the image decoding method comprising: determining a prediction mode of a current block based on prediction mode information of the current block; determining whether intra sub-partitions, ISP, is available for the current block, based on the prediction mode of the current block being an intra prediction mode; decoding ISP mode information for the current block, based on the ISP being available for the current block; and generating a prediction block for the current block by applying the ISP to the current block based on the ISP mode information, wherein the determining whether the ISP is available for the current block is performed based on comparison between a size of a luma component block of the current block and a specific threshold, and wherein, a flag related to whether the current block is partitioned into subpartitions is parsed based on intra_luma_ref_idx is 0 and both a width and height of the luma component block of the current block being equal to or less than the specific threshold. determining a prediction mode of a current block based on prediction mode information of the current block; determining whether intra sub-partitions, ISP, is available for the current block, based on the prediction mode of the current block being an intra prediction mode; decoding ISP mode information for the current block, based on the ISP being available for the current block; and generating a prediction block for the current block by applying the ISP to the current block based on the ISP mode information, wherein the determining whether the ISP is available for the current block is performed based on comparison between a size of a luma component block of the current block and a specific threshold, and wherein, a flag related to whether the current block is partitioned into subpartitions is parsed based on intra_luma_ref_idx is 0 and both a width and height of the luma component block of the current block being equal to or less than the specific threshold.
Motor-vehicle bodywork, with a rear entrance intended to be closed by a hatch and delimited by a channel, said bodywork comprising: - a front element forming a lining for the channel; - a rear element forming said channel, said element being fixed to the front element with a view to forming a hollow body extending generally vertically; - a stiffener situated inside the hollow body; characterised in that the stiffener comprises: - a first partition fixed to the front element and extending as far as the rear element; - a second partition fixed to the rear element; and - means for rapid fixing between the first and second partitions so as to allow fixing of said partitions when said front and rear elements are assembled. - a front element forming a lining for the channel; - a rear element forming said channel, said element being fixed to the front element with a view to forming a hollow body extending generally vertically; - a stiffener situated inside the hollow body; - a first partition fixed to the front element and extending as far as the rear element; - a second partition fixed to the rear element; and - means for rapid fixing between the first and second partitions so as to allow fixing of said partitions when said front and rear elements are assembled.
A method for detecting a target miRNA molecule in a sample, the method comprising: reverse transcribing the target miRNA contained in the sample using an RT oligonucleotide, the RT oligonucleotide comprising a stem-loop portion containing one or more nucleotides modified or cleavable to block DNA polymerase extension and a target annealing portion that is complementary to a downstream portion of the target miRNA, the target annealing portion located 3' to the stem-loop portion, to produce a reverse transcription product that comprises the RT oligonucleotide and a 3' extended region; amplifying the reverse transcription product using (i) a first amplification primer that anneals to a downstream portion of the 3' extended region of the reverse transcription product and (ii) a second amplification primer that anneals to an interface portion of a DNA strand complementary to the reverse transcription product, the interface portion comprising a region that is complementary to a 3' portion of the RT oligonucleotide and a 5' portion of the 3' extended region in the reverse transcription product, to produce an amplification product; and detecting the amplification product; wherein the stem-loop portion adopts a stem-loop structure under conditions used for said reverse transcribing but does not adopt the stem-loop structure under conditions used for said amplifying and wherein when the stem-loop portion contains one or more nucleotides that are cleavable to block DNA polymerase extension, the method further comprises cleaving the nucleotide(s) prior to said amplifying. reverse transcribing the target miRNA contained in the sample using an RT oligonucleotide, the RT oligonucleotide comprising a stem-loop portion containing one or more nucleotides modified or cleavable to block DNA polymerase extension and a target annealing portion that is complementary to a downstream portion of the target miRNA, the target annealing portion located 3' to the stem-loop portion, to produce a reverse transcription product that comprises the RT oligonucleotide and a 3' extended region; amplifying the reverse transcription product using (i) a first amplification primer that anneals to a downstream portion of the 3' extended region of the reverse transcription product and (ii) a second amplification primer that anneals to an interface portion of a DNA strand complementary to the reverse transcription product, the interface portion comprising a region that is complementary to a 3' portion of the RT oligonucleotide and a 5' portion of the 3' extended region in the reverse transcription product, to produce an amplification product; and detecting the amplification product;
Holding frame that can receive plug connector modules, wherein the holding frame comprises two halves (4, 5), a first half and a second half, which can be connected to one another in an articulated manner, wherein the halves (4, 5) can be oriented in different angular positions with respect to one another along a parting line, characterized in - that the holding frame comprises at least one first locking element and - that the second half of the holding frame comprises at the end face a peg and the first locking element comprises at least two recesses (12, 12'), wherein the peg can engage into the at least two recesses (12, 12') or that the second half of the holding frame comprises at the end face at least two pegs and the first locking element comprises a recess, wherein the at least two pegs can engage in each case into the recess and - as a consequence the halves (4, 5) can be fixed in an open position or in a closed position, - that the halves (4, 5) enclose an angle (α) between 130° to 170° with one another in the open position, and in that the halves (4, 5) enclose an angle (α) of 180° with one another in the closed position, and - that the first locking element is fixed at one end to the first half of the holding frame and at the other end is connected in a positive locking and/or non-positive locking manner to the second half of the holding frame. - that the holding frame comprises at least one first locking element and - that the second half of the holding frame comprises at the end face a peg and the first locking element comprises at least two recesses (12, 12'), wherein the peg can engage into the at least two recesses (12, 12') or that the second half of the holding frame comprises at the end face at least two pegs and the first locking element comprises a recess, wherein the at least two pegs can engage in each case into the recess and - as a consequence the halves (4, 5) can be fixed in an open position or in a closed position, - that the halves (4, 5) enclose an angle (α) between 130° to 170° with one another in the open position, and in that the halves (4, 5) enclose an angle (α) of 180° with one another in the closed position, and - that the first locking element is fixed at one end to the first half of the holding frame and at the other end is connected in a positive locking and/or non-positive locking manner to the second half of the holding frame.
Flat body formed as a chip card for biochemical analysis of substances, with at least two microfluidic devices (3, 4) and with at least one sensor chip, wherein the at least one sensor chip is integrated in the flat body and in direct contact with at least one first microfluidic device, and wherein the flat body includes integrally a second microfluidic device, which has an elongate design and at one end has a tip with a fluidic opening, characterized in that the flat body comprises a first clamping device which is configured to attach a cover of a reaction vessel onto the flat body in a direct mechanical manner.
A heat exchanger assembly, comprising: a shell having a core disposed therein, the core being provided with a plurality of first fluid channels and a plurality of second fluid channels; a first inlet duct that includes a plurality of first feed channels extending towards and fluidly connected to the plurality of first fluid channels; a first outlet duct operatively connected to the shell and wherein the first outlet duct is arranged opposite the first inlet duct along a first axis between the shell and a first mounting flange; a second inlet duct that includes a plurality of second feed channels extending towards and fluidly connected to the plurality of second fluid channels, the plurality of first feed channels being interwoven with the plurality of second feed channels; a second outlet duct operatively connected to the shell and characterised in that the second outlet duct is arranged opposite the second inlet duct along a second axis between the shell and a second mounting flange; wherein the shell is a spherical shell and wherein the core is a spherical core; and wherein the first and second axes (42, 46) are orthogonal to each other. a shell having a core disposed therein, the core being provided with a plurality of first fluid channels and a plurality of second fluid channels; a first inlet duct that includes a plurality of first feed channels extending towards and fluidly connected to the plurality of first fluid channels; a first outlet duct operatively connected to the shell and wherein the first outlet duct is arranged opposite the first inlet duct along a first axis between the shell and a first mounting flange; a second inlet duct that includes a plurality of second feed channels extending towards and fluidly connected to the plurality of second fluid channels, the plurality of first feed channels being interwoven with the plurality of second feed channels; a second outlet duct operatively connected to the shell and characterised in that the second outlet duct is arranged opposite the second inlet duct along a second axis between the shell and a second mounting flange; wherein the shell is a spherical shell and wherein the core is a spherical core; and wherein the first and second axes (42, 46) are orthogonal to each other.
Use of an antibody, or functional fragments thereof, for isolating and/or identifying homogenous mesenchymal stem cells from primary tissues, whereby the antibody is chosen from the group consisting of antibodies directed against CD340, against CD140b, against CD56, or antibodies W8B2, W1C3, W7C6, W5C4, HEK-3D6, W4A5, W3D5, W5C5, 9A3G2, 58B1, or F9-3C2, which are produced by the hybridoma cell lines which are deposited, in accordance with the Budapest Treaty, at the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) under the numbers DSM ACC ACC 2567 (W8B2), DSM ACC 2816 (W1C3), DSM ACC 2821 (W7C6), DSM ACC 2814 (W5C4), DSM ACC 2817 (HEK-3D6), DSM ACC 2815 (W3D5), DSM ACC 2813 (W5C5), DSM ACC 2820 (9A3G2), DSM ACC 2571 (W4A5), DSM ACC 2819 (58B1), DSM ACC 2818 (F9-3C2).
Rocket propulsion system comprising a first cryogenic tank and a second cryogenic tank, wherein the first cryogenic tank is filled with a first propellant and the second cryogenic tank is filled with a second propellant to supply at least one repeatedly ignitable main propulsion unit in a propulsion phase of the rocket propulsion system, wherein in a ballistic phase a first auxiliary propulsion unit is operable by means of a first gas pressure accumulator, and at least one further auxiliary propulsion unit is operable by means of a further gas pressure accumulator in order to pressurise the tank by means of at least a slight acceleration, and an energy conversion unit is assigned to the rocket propulsion system, characterized in that the energy conversion unit is designed to at least generate electrical energy and to charge the first and second gas pressure accumulators (152, 156), preferably in the ballistic phase.
A retrieval system for use in retrieving an elongated percutaneously-implanted implant or instrument having a tube that defines a lumen, comprising: a tubular extension member having a connector sized to extend within the lumen of the tube and attach thereto, the tubular extension member having a length, wherein the connector comprises an expandable auxetic section adapted to radially expand into contact with the lumen of the tube when subjected to a tensile force.
Method for controlling a heater output stage of a heating element of a lambda probe of a motor vehicle, wherein the heating element is actuated by means of the heater output stage and has a heating voltage (U H) applied to it, and wherein the actuation of the heater output stage is performed in a regulated manner by means of pulse-width modulation, wherein, directly within an item of hardware of the heater output stage at the end of the actuation chain, monitoring is performed in respect of whether the heater output stage connects a supply voltage to the heating element of the lambda probe in an uninterrupted manner for longer than a prespecified time threshold, and connection of the supply voltage to the heating element of the lambda probe is terminated by the item of hardware of the heater output stage at the end of the actuating chain by active deactivation if the prespecified time threshold is exceeded.
A heart treatment system, comprising: an implantable blood pump configured to couple with a circulatory system of a patient and to pump blood therethrough, the implantable blood pump comprising a pump processor; and an implantable cardiac rhythm management device configured to deliver heart stimulation pulses to a heart of the patient, wherein the implantable cardiac rhythm management device is further configured to deliver a series of electrical pulses (200a-200d) to the pump processor of the implantable blood pump through wireless communication; and wherein the pump processor of the implantable blood pump is configured to receive the series of electrical pulses (200a-200d) comprising one or more pulses associated with an electrical pace signal and one or more pulses associated with a type of abnormal heart rhythm detected by the implantable cardiac rhythm management device, to determine the type of abnormal heart rhythm detected by the implantable cardiac rhythm management device, and to adjust a pumping of the implantable blood pump based on the type of abnormal heart rhythm. an implantable blood pump configured to couple with a circulatory system of a patient and to pump blood therethrough, the implantable blood pump comprising a pump processor; and an implantable cardiac rhythm management device configured to deliver heart stimulation pulses to a heart of the patient, wherein the implantable cardiac rhythm management device is further configured to deliver a series of electrical pulses (200a-200d) to the pump processor of the implantable blood pump through wireless communication; and wherein the pump processor of the implantable blood pump is configured to receive the series of electrical pulses (200a-200d) comprising one or more pulses associated with an electrical pace signal and one or more pulses associated with a type of abnormal heart rhythm detected by the implantable cardiac rhythm management device, to determine the type of abnormal heart rhythm detected by the implantable cardiac rhythm management device, and to adjust a pumping of the implantable blood pump based on the type of abnormal heart rhythm.
A method of operating a drone-coupled user equipment, UE, wherein the UE is physically and/or communicatively coupled to a drone, the UE comprising: determining whether the drone-coupled UE is engaged in a flying state, wherein the drone-coupled UE is assigned a first identifier for use in the flying state and a second identifier for use in a non-flying state; and transmitting a message to a network component of a terrestrial wireless communication subscriber network that indicates a result of the determining, wherein the message is configured to include either the first or second identifier to indicate the result of the determining. determining whether the drone-coupled UE is engaged in a flying state, wherein the drone-coupled UE is assigned a first identifier for use in the flying state and a second identifier for use in a non-flying state; and transmitting a message to a network component of a terrestrial wireless communication subscriber network that indicates a result of the determining, wherein the message is configured to include either the first or second identifier to indicate the result of the determining.
A synergistic microbicidal composition comprising of lactic acid and phenethyl alcohol, wherein the weight ratio of lactic acid to phenethyl alcohol is 4:1 to 1:1.25.
A polypeptide comprising an RNase and a variant Fc domain, wherein the RNase is operatively coupled, optionally with a linker, to the variant Fc domain, wherein the variant Fc domain is a variant human IgG1 Fc domain comprising an amino acid substitution which decreases binding, compared to wild-type, to an Fcγ receptor or a complement protein or both, wherein the polypeptide has a reduced effector function optionally selected from the group consisting of opsonization, phagocytosis, complement dependent cytotoxicity, and antibody-dependent cellular cytotoxicity.
Method for producing a microporous membrane, on whose surface a polymer crosslinked by electron beam radiation is fixed, wherein the method comprises the steps of: a) providing a microporous starting membrane, b) impregnating the membrane with an impregnating solution comprising a solvent and a polymer dissolved or dispersed therein to provide an impregnated membrane, and c) irradiating the impregnated membrane with electron beam radiation to provide a microporous membrane, on whose surface the polymer crosslinked by electron beam radiation is fixed, wherein in step b) a polymer is used which is an organic substance which has an average molecular weight of at least 500 g/mol and which is selected from the group consisting of polyethylene glycol, polyethylene oxide, polypropylene oxide, hydroxyethyl cellulose, dextran, hydroxymethyl cellulose, PEO-PPO-PEO-triblock copolymers and mixtures thereof and wherein the electron irradiation is effected using a dose in the range of 1 to 300 kGy. a) providing a microporous starting membrane, b) impregnating the membrane with an impregnating solution comprising a solvent and a polymer dissolved or dispersed therein to provide an impregnated membrane, and c) irradiating the impregnated membrane with electron beam radiation to provide a microporous membrane, on whose surface the polymer crosslinked by electron beam radiation is fixed,
A structure to neutralise odours, comprising a rail section (1, 50, 100) arranged to allow the hanging, on the section, of a stretched fabric in order to produce a false partition and at least one filter cartridge containing a specific odour-sorbent material, said cartridge being housed in a groove (7, 57) of the rail section.
Method for preparing nanostructured zinc oxide (ZnO) layers on a substrate selected from a group consisting of glass, metal oxide covered glass, silicon and quartz, said layers comprising nanostructures chosen from the group of nanostructures consisting of ZnO nanorods and nanoneedles, said substrate having a first surface and a second surface, the method comprising the steps of: heating the substrate to a predetermined temperature, wherein said predetermined temperature is from 400°C to 600°C; atomizing a solution, comprising a precursor and a solvent and thiourea (SC(NH 2) 2) or urea (OC(NH 2) 2), wherein said solvent is selected from the group of H 2 O and alcohol, into small discrete droplets using spray technique, wherein said precursor is zinc chloride (ZnCl 2); and depositing the atomized solution on the first surface of the substrate, using predetermined solution feeding rate, wherein the solvent evaporates when reaching the substrate, and said precursor reacts to form said nanostructured zinc oxide layer. heating the substrate to a predetermined temperature, wherein said predetermined temperature is from 400°C to 600°C; atomizing a solution, comprising a precursor and a solvent and thiourea (SC(NH 2) 2) or urea (OC(NH 2) 2), wherein said solvent is selected from the group of H 2 O and alcohol, into small discrete droplets using spray technique, wherein said precursor is zinc chloride (ZnCl 2); and depositing the atomized solution on the first surface of the substrate, using predetermined solution feeding rate, wherein the solvent evaporates when reaching the substrate, and said precursor reacts to form said nanostructured zinc oxide layer.